Mitochondrial comparative proteomics of human ovarian cancer cells and their platinum-resistant sublines.
about
Proteomics of ovarian cancer: functional insights and clinical applicationsInteractome Mapping Guided by Tissue-Specific Phosphorylation in Age-Related Macular Degeneration.Down-regulation of Ras-related protein Rab 5C-dependent endocytosis and glycolysis in cisplatin-resistant ovarian cancer cell lines.Quantitative proteomic analysis of mitochondria from human ovarian cancer cells and their paclitaxel-resistant sublinesCancer as a mitochondrial metabolic disease.Comparative Proteomic Analysis of Advanced Ovarian Cancer Tissue to Identify Potential Biomarkers of Responders and Nonresponders to First-Line Chemotherapy of Carboplatin and Paclitaxel.Proteomics revisits the cancer metabolome.The proteomics of cancer stem cells: potential clinical applications for innovative research in oncology.Signaling pathways of prohibitin and its role in diseases.Hyper-phosphorylation of Sequestosome-1 Distinguishes Resistance to Cisplatin in Patient Derived High Grade Serous Ovarian Cancer Cells.Proteomics discovery of chemoresistant biomarkers for ovarian cancer therapy.In vitro characterization of a novel C,N-cyclometalated benzimidazole Ru(II) arene complex: stability, intracellular distribution and binding, effects on organic osmolyte homeostasis and induction of apoptosis.Prediction of therapy response in ovarian cancer: Where are we now?Adseverin: a novel cisplatin-resistant marker in the human bladder cancer cell line HT1376 identified by quantitative proteomic analysis.Proteomic analysis of mitochondria: biological and clinical progresses in cancer.Platelet protein biomarker panel for ovarian cancer diagnosis.Significance of prohibitin domain family in tumorigenesis and its implication in cancer diagnosis and treatment.
P2860
Q28082632-927F5C6F-E6E3-45C5-8191-2F50AAC3CF57Q33743986-E6F0CBB2-516A-4C2E-99D4-51901A24C92CQ34468400-3C2FFD8B-536F-4C55-9AC3-DD90B568B604Q35649272-0368014D-2FBB-4A05-A307-DF1AC9E6A74BQ35824628-A093D55F-C48B-48A0-84E1-B2DDEA23B3CEQ36696710-9BDEC7B4-D065-420E-9E17-22AF7FED174BQ37912205-98FE09CD-5D49-442A-9229-273544278F43Q37940376-6415532D-AB43-4AD8-B27B-EB96F603293BQ38074717-96228162-9A41-4475-8BB8-E5D2F7B40205Q38705569-84F2C643-62CE-4F84-9A17-4EDA9DAA6DB0Q38824059-DF723C63-F1EE-4A36-A8E7-9DF2314A89A5Q38895597-BF7FFF2D-5B9A-4F88-AF72-A1CA213D4A20Q39263260-B747FF76-DA49-46BF-BCCC-D4B939845612Q39408732-D35A67EE-687B-47CF-8BA7-A4764EDEEC2DQ47729926-89CF8660-8081-4EBA-B892-6E08940F8225Q48222655-A2692227-4777-440F-878B-D70B6E0744CCQ55253157-E68177A8-6711-4945-A60E-648FE361CFBC
P2860
Mitochondrial comparative proteomics of human ovarian cancer cells and their platinum-resistant sublines.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Mitochondrial comparative prot ...... r platinum-resistant sublines.
@ast
Mitochondrial comparative prot ...... r platinum-resistant sublines.
@en
type
label
Mitochondrial comparative prot ...... r platinum-resistant sublines.
@ast
Mitochondrial comparative prot ...... r platinum-resistant sublines.
@en
prefLabel
Mitochondrial comparative prot ...... r platinum-resistant sublines.
@ast
Mitochondrial comparative prot ...... r platinum-resistant sublines.
@en
P2093
P356
P1433
P1476
Mitochondrial comparative prot ...... r platinum-resistant sublines.
@en
P2093
Chunmei Hou
Lingya Pan
Xiaohong Qian
Zhiqin Dai
P2860
P304
P356
10.1002/PMIC.200900685
P577
2010-11-01T00:00:00Z